The NIHR Cambridge Biomedical Research Centre (BRC) has announced Dr Miles Parkes will be the new director of the centre, based at Cambridge University Hospitals (CUH).
Dr Miles Parkes is currently a consultant gastroenterologist and researcher at CUH.
His research focuses on understanding the causes of Crohn’s disease and ulcerative colitis, and the factors that affect the course and outcomes of treatment for these conditions – by focusing on their genetics and the gut microbiota. In addition he researches new ways of managing and treating Crohn’s disease and ulcerative colitis.
Miles already leads the UK IBD genetics consortium and is also the clinical and academic lead for the recently established Health Data Research Hub for IBD, known as Gut Reaction.
Miles will take over the role from Professor John Bradley, who announced in late 2019 he would be stepping down from his director role at the NIHR Cambridge BRC. John will still play an integral part in the development of research on the Cambridge Biomedical Campus as he continues to be joint director of the NIHR BioResource and Research and Development Director at CUH.
For more information visit: NIHR Cambridge BRC
Pharmaceutical outsourcing specialist Quay Pharma’s acknowledged…
As part of a new trial led by Cambridge University Hospitals and supported by NIHR Cambridge Biomedical Research Centre, a microbe will be used to treat…